These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24246132)

  • 1. Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation.
    Fayed NA; Abdallah AR; Khalil MK; Marwan IK
    Platelets; 2014; 25(8):576-86. PubMed ID: 24246132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
    Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
    J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
    Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for pediatric patients requiring massive blood transfusion during living donor liver transplantation.
    Huang CJ; Cheng KW; Chen CL; Wu SC; Shih TH; Yang SC; Jawan B; Wang CH
    Ann Transplant; 2013 Sep; 18():443-7. PubMed ID: 23999839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors.
    Crowther MA; Cook DJ; Meade MO; Griffith LE; Guyatt GH; Arnold DM; Rabbat CG; Geerts WH; Warkentin TE
    J Crit Care; 2005 Dec; 20(4):348-53. PubMed ID: 16310606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.
    Federici AB; Intini D; Lattuada A; Vanelli C; Arrigoni L; Sacchi E; Russo U
    Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic splenectomy for patients with immune thrombocytopenia and very low platelet count: is platelet transfusion necessary?
    Chen X; Peng B; Cai Y; Zhou J; Wang Y; Wu Z; Chen S
    J Surg Res; 2011 Oct; 170(2):e225-32. PubMed ID: 21816423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
    Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation defects do not predict blood product requirements during liver transplantation.
    Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
    Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit of platelet transfusion within the Wellington Cancer Centre.
    Buhrkuhl DC; Karlsson MK; Carter JM
    Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining Transfusion Triggers and Utilization of Fresh Frozen Plasma and Platelets Among Patients Undergoing Hepatopancreaticobiliary and Colorectal Surgery.
    Ejaz A; Frank SM; Spolverato G; Kim Y; Pawlik TM
    Ann Surg; 2015 Dec; 262(6):1079-85. PubMed ID: 25985254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of autologous platelet transfusion in cardiac surgery: comparison of cryopreservation, blood collection on the day before surgery, and blood collection during surgery.
    Yokomuro M; Ebine K; Shiroma K; Tamura S; Kumabe S; Ohtuki M; Suzuki H; Uchida S
    Cryobiology; 1999 May; 38(3):236-42. PubMed ID: 10328913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.
    Tripodi A; Primignani M; Chantarangkul V; Lemma L; Jovani M; Rebulla P; Mannucci PM
    Liver Int; 2013 Mar; 33(3):362-7. PubMed ID: 23231699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients.
    Schlenke P; Hagenah W; Irsch J; Sundin D; Corash L; Lin L; Kirchner H; Wagner T
    Ann Hematol; 2011 Dec; 90(12):1457-65. PubMed ID: 21503644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia.
    Ramos GP; Binder M; Hampel P; Braga Neto MB; Sunjaya D; Al Bawardy B; Abu Dayyeh BK; Buttar NS; Bruining DH; Prabhu-Coelho N; Larson MV; Wong Kee Song LM; Rajan E
    Gastrointest Endosc; 2018 Jul; 88(1):55-61. PubMed ID: 29408558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
    Diedrich B; Ringdén O; Watz E; Shanwell A
    Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study.
    Zamper RPC; Amorim TC; Queiroz VNF; Lira JDO; Costa LGV; Takaoka F; Juffermans NP; Neto AS
    BMC Anesthesiol; 2018 Dec; 18(1):198. PubMed ID: 30579327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.